Literature DB >> 20335254

Different in vivo effects of HIV-1 immunodominant epitope-specific cytotoxic T lymphocytes on selection of escape mutant viruses.

Hirokazu Koizumi1, Masao Hashimoto, Mamoru Fujiwara, Hayato Murakoshi, Takayuki Chikata, Mohamed Ali Borghan, Atsuko Hachiya, Yuka Kawashima, Hiroshi Takata, Takamasa Ueno, Shinichi Oka, Masafumi Takiguchi.   

Abstract

HIV-1 escape mutants are well known to be selected by immune pressure via HIV-1-specific cytotoxic T lymphocytes (CTLs) and neutralizing antibodies. The ability of the CTLs to suppress HIV-1 replication is assumed to be associated with the selection of escape mutants from the CTLs. Therefore, we first investigated the correlation between the ability of HLA-A*1101-restricted CTLs recognizing immunodominant epitopes in vitro and the selection of escape mutants. The result showed that there was no correlation between the ability of these CTLs to suppress HIV-1 replication in vitro and the appearance of escape mutants. The CTLs that had a strong ability to suppress HIV-1 replication in vitro but failed to select escape mutants expressed a higher level of PD-1 in vivo, whereas those that had a strong ability to suppress HIV-1 replication in vitro and selected escape mutants expressed a low level of PD-1. Ex vivo analysis of these CTLs revealed that the latter CTLs had a significantly stronger ability to recognize the epitope than the former ones. These results suggest that escape mutations are selected by HIV-1-specific CTLs that have a stronger ability to recognize HIV-1 in vivo but not in vitro.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20335254      PMCID: PMC2876605          DOI: 10.1128/JVI.02483-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

Review 1.  The B7-CD28 superfamily.

Authors:  Arlene H Sharpe; Gordon J Freeman
Journal:  Nat Rev Immunol       Date:  2002-02       Impact factor: 53.106

2.  Structural and functional analysis of monomorphic determinants recognized by monoclonal antibodies reacting with the HLA class I alpha 3 domain.

Authors:  M Tanabe; M Sekimata; S Ferrone; M Takiguchi
Journal:  J Immunol       Date:  1992-05-15       Impact factor: 5.422

3.  Assessment of major histocompatibility complex class I interaction with Epstein-Barr virus and human immunodeficiency virus peptides by elevation of membrane H-2 and HLA in peptide loading-deficient cells.

Authors:  G Stuber; S Modrow; P Höglund; L Franksson; J Elvin; H Wolf; K Kärre; G Klein
Journal:  Eur J Immunol       Date:  1992-10       Impact factor: 5.532

Review 4.  Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity.

Authors:  Lieping Chen
Journal:  Nat Rev Immunol       Date:  2004-05       Impact factor: 53.106

5.  Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition.

Authors:  R E Phillips; S Rowland-Jones; D F Nixon; F M Gotch; J P Edwards; A O Ogunlesi; J G Elvin; J A Rothbard; C R Bangham; C R Rizza
Journal:  Nature       Date:  1991-12-12       Impact factor: 49.962

6.  Empty MHC class I molecules come out in the cold.

Authors:  H G Ljunggren; N J Stam; C Ohlén; J J Neefjes; P Höglund; M T Heemels; J Bastin; T N Schumacher; A Townsend; K Kärre
Journal:  Nature       Date:  1990-08-02       Impact factor: 49.962

7.  Nef-mediated resistance of human immunodeficiency virus type 1 to antiviral cytotoxic T lymphocytes.

Authors:  Otto O Yang; Phuong Thi Nguyen; Spyros A Kalams; Tanya Dorfman; Heinrich G Göttlinger; Sheila Stewart; Irvin S Y Chen; Steven Threlkeld; Bruce D Walker
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

8.  Impaired processing and presentation of cytotoxic-T-lymphocyte (CTL) epitopes are major escape mechanisms from CTL immune pressure in human immunodeficiency virus type 1 infection.

Authors:  Yoshiyuki Yokomaku; Hideka Miura; Hiroko Tomiyama; Ai Kawana-Tachikawa; Masafumi Takiguchi; Asato Kojima; Yoshiyuki Nagai; Aikichi Iwamoto; Zene Matsuda; Koya Ariyoshi
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

9.  Different effects of Nef-mediated HLA class I down-regulation on human immunodeficiency virus type 1-specific CD8(+) T-cell cytolytic activity and cytokine production.

Authors:  Hiroko Tomiyama; Hirofumi Akari; Akio Adachi; Masafumi Takiguchi
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

10.  Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death.

Authors:  Y Ishida; Y Agata; K Shibahara; T Honjo
Journal:  EMBO J       Date:  1992-11       Impact factor: 11.598

View more
  6 in total

1.  Clinical Control of HIV-1 by Cytotoxic T Cells Specific for Multiple Conserved Epitopes.

Authors:  Hayato Murakoshi; Tomohiro Akahoshi; Madoka Koyanagi; Takayuki Chikata; Takuya Naruto; Rie Maruyama; Yoshiko Tamura; Naoki Ishizuka; Hiroyuki Gatanaga; Shinichi Oka; Masafumi Takiguchi
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

Review 2.  PD-1 coinhibitory signals: the link between pathogenesis and protection.

Authors:  Deanna A Kulpa; Mariam Lawani; Anthony Cooper; Yoav Peretz; Jeff Ahlers; Rafick-Pierre Sékaly
Journal:  Semin Immunol       Date:  2013-03-31       Impact factor: 11.130

3.  Lack of recall response to Tax in ATL and HAM/TSP patients but not in asymptomatic carriers of human T-cell leukemia virus type 1.

Authors:  Sharrón L Manuel; Mohit Sehgal; John Connolly; George Makedonas; Zafar K Khan; Jay Gardner; Michael R Betts; Pooja Jain
Journal:  J Clin Immunol       Date:  2013-07-26       Impact factor: 8.317

4.  Direct interrogation of viral peptides presented by the class I HLA of HIV-infected T cells.

Authors:  Jane C Yaciuk; Matthew Skaley; Wilfried Bardet; Fredda Schafer; Danijela Mojsilovic; Steven Cate; Christopher J Stewart; Curtis McMurtrey; Kenneth W Jackson; Rico Buchli; Alex Olvera; Samandhy Cedeño; Montserrat Plana; Beatriz Mothe; Christian Brander; John T West; William H Hildebrand
Journal:  J Virol       Date:  2014-08-27       Impact factor: 5.103

5.  CTL escape mediated by proteasomal destruction of an HIV-1 cryptic epitope.

Authors:  Sylvain Cardinaud; Gesa Consiglieri; Romain Bouziat; Alejandra Urrutia; Stéphanie Graff-Dubois; Slim Fourati; Isabelle Malet; Julien Guergnon; Amélie Guihot; Christine Katlama; Brigitte Autran; Peter van Endert; François A Lemonnier; Victor Appay; Olivier Schwartz; Peter M Kloetzel; Arnaud Moris
Journal:  PLoS Pathog       Date:  2011-05-12       Impact factor: 6.823

6.  Effective Suppression of HIV-1 Replication by Cytotoxic T Lymphocytes Specific for Pol Epitopes in Conserved Mosaic Vaccine Immunogens.

Authors:  Chengcheng Zou; Hayato Murakoshi; Nozomi Kuse; Tomohiro Akahoshi; Takayuki Chikata; Hiroyuki Gatanaga; Shinichi Oka; Tomáš Hanke; Masafumi Takiguchi
Journal:  J Virol       Date:  2019-03-21       Impact factor: 5.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.